Kirn David
Insider CIK 1834021 · FDMT See Remarks, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-10-05 | 2026-10-07 | 272 | $13.61 | $3.7K | 709,153 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-10-05 | 2026-10-07 | 58,061 | $12.92 | $750.2K | 709,425 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-09-14 | 2026-09-16 | 58,333 | $13.90 | $810.8K | 767,486 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-09-14 | 2026-09-16 | 58,333 | $13.90 | $811.0K | 767,486 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-08-19 | 2026-08-21 | 50,000 | — | $0 | 217,500 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-08-19 | 2026-08-21 | 50,000 | $4.14 | $207.0K | 894,895 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-19 | 2026-08-21 | 25,927 | $16.42 | $425.7K | 825,819 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-19 | 2026-08-21 | 43,149 | $15.36 | $662.8K | 851,746 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-08-19 | 2026-08-21 | 50,000 | — | $0 | 217,500 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-19 | 2026-08-21 | 25,927 | $16.42 | $425.7K | 825,819 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-19 | 2026-08-21 | 43,149 | $15.36 | $662.6K | 851,746 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-08-19 | 2026-08-21 | 50,000 | $4.14 | $207.0K | 894,895 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-04 | 2026-08-05 | 26,842 | $10.23 | $274.6K | 844,895 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-04 | 2026-08-05 | 26,842 | $10.23 | $274.6K | 844,895 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-03 | 2026-08-04 | 12,415 | $10.05 | $124.8K | 871,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-03 | 2026-08-04 | 12,415 | $10.05 | $124.7K | 871,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-07-10 | 2026-07-14 | 442 | $12.84 | $5.7K | 884,152 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-07-10 | 2026-07-14 | 15,283 | $12.01 | $183.5K | 884,594 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-07-09 | 2026-07-14 | 42,608 | $12.87 | $548.4K | 899,877 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-06-22 | 2026-06-23 | 114,746 | $10.47 | $1.20M | 942,485 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-06-01 | 2026-06-02 | 1,922 | $10.02 | $19.3K | 1,057,231 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2026-03-25 | 2026-03-27 | 750,000 | — | $0 | 750,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2025-03-06 | 2025-03-10 | 267,500 | — | $0 | 267,500 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-07-10 | 2024-07-12 | 11,653 | — | $0 | 565,417 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-07-10 | 2024-07-12 | 1,270 | — | $0 | 148,730 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-07-10 | 2024-07-12 | 12,923 | $22.49 | $290.6K | 1,059,153 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-07-10 | 2024-07-12 | 1,270 | $15.78 | $20.0K | 1,072,076 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-07-10 | 2024-07-12 | 11,653 | $14.42 | $168.0K | 1,070,806 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-06-24 | 2024-06-26 | 12,930 | — | $0 | 577,070 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-06-24 | 2024-06-26 | 12,930 | $14.42 | $186.5K | 1,072,083 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-06-24 | 2024-06-26 | 12,930 | $23.10 | $298.7K | 1,059,153 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-08 | 2024-02-12 | 92,001 | $27.13 | $2.50M | 1,059,153 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-01-23 | 2024-01-25 | 5,696 | $18.41 | $104.9K | 1,151,154 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-01-05 | 2024-01-08 | 28,104 | $19.56 | $549.7K | 1,156,983 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-01-05 | 2024-01-08 | 133 | $20.11 | $2.7K | 1,156,850 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-01-04 | 2024-01-08 | 40,732 | $20.31 | $827.3K | 1,185,087 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-12-18 | 2024-01-08 | 4,702 | $18.13 | $85.2K | 1,225,819 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-12-15 | 2024-01-08 | 28,632 | $17.27 | $494.5K | 1,230,521 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2023-12-11 | 2023-12-13 | 590,000 | — | $0 | 590,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | G Gift | 2023-05-02 | 2023-05-04 | 600,000 | — | $0 | 600,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | G Gift | 2023-05-02 | 2023-05-04 | 600,000 | — | $0 | 1,259,153 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-02-22 | 2023-02-23 | 16,449 | $20.22 | $332.6K | 1,859,153 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-02-21 | 2023-02-23 | 907 | $21.49 | $19.5K | 1,875,602 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-02-21 | 2023-02-23 | 17,090 | $20.93 | $357.7K | 1,876,509 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2023-02-10 | 2023-02-14 | 222,000 | — | $0 | 222,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-01-20 | 2023-01-23 | 8,625 | $20.19 | $174.1K | 1,893,599 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-01-19 | 2023-01-23 | 10,899 | $20.03 | $218.3K | 1,902,224 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-16 | 2022-12-19 | 27,595 | $22.66 | $625.3K | 1,939,472 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-16 | 2022-12-19 | 26,349 | $23.39 | $616.3K | 1,913,123 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-15 | 2022-12-19 | 1,500 | $24.13 | $36.2K | 1,967,067 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-15 | 2022-12-19 | 31,433 | $23.56 | $740.6K | 1,968,567 | SEC↗ |
| FDMT 4D Molecular Therapeutics | A Award deriv | 2022-02-01 | 2022-02-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics | A Award deriv | 2021-03-08 | 2021-03-10 | 150,000 | — | $0 | 150,000 | SEC↗ |